Myomo Inc

MYO NYSE Healthcare & Biotech United States US62857J2015
1.44 $
12.11 %

Myomo Inc develops and markets innovative robotic assistive devices to support upper limb functions in individuals with neurological or nerve disorders.

Price history of Myomo Inc
Price history of Myomo Inc

Performance & Momentum

6 Months 10.19 %
1 Year 63.19 %
3 Years 87.61 %
5 Years 89.54 %

Strategic Analysis

Myomo Inc • 2026

Myomo Inc is positioned in a highly specialized niche of medical technology, with wearable powered orthoses intended for rehabilitation and functional assistance. Its model is built on a clear clinical value proposition at the intersection of medical devices, neurology, and rehabilitation, giving it a defensible but narrow niche.

Strengths
  • Niche positioning in specific medical needs that are not easily substituted in the near term
  • Exposure to a digital health theme with potential for clinical and commercial re-rating
  • Product specialization that can foster strong differentiation versus more generalist players
Weaknesses
  • Very fragile stock market history, signaling a prolonged deterioration in investor confidence
  • Small-cap profile likely sensitive to commercial, regulatory, and financing risks
Momentum

Momentum appears to be improving tactically, with a recent rebound that contrasts with an underlying trend that remains highly choppy. Despite this more constructive short-term signal, the stock’s history remains volatile and underscores that the name is still speculative; the strategic appeal is mainly that of a technical recovery that must be confirmed by durable operating progress.

Similar stocks to Myomo Inc

Was this page helpful?

Your feedback helps us improve our research.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases
Anantys Invest on iPhone